Journal Impact Factor
http://www.pubmedplus.cn/P/SearchQuickResult?wd=6ca4d8d3-87c3-4c42-80f4-3041a423cb8b
📈 3. 2025 JIF Highlights
Top Journals: CA: A Cancer Journal for Clinicians remained the top-ranked journal, though its JIF decreased to 232.4 (from 503.1 in 2024)246.
Major medical journals like The New England Journal of Medicine (78.5), The Lancet (88.5), JAMA (55.0), and BMJ (42.7) saw declines in their JIFs467.
Nature (48.5), Cell (42.5), and Science (45.8) remained top-tier, with Science showing a slight increase67.
Strong Performance of Chinese Journals: Chinese journals demonstrated significant growth, with 719 journals listed (585 from mainland China, 53 from Hong Kong, and 81 from Taiwan). Notable examples include:
Signal Transduction and Targeted Therapy (JIF: 52.7)467.
eScience (JIF: 36.6)47.
💎 Conclusion
The 2025 JIF reflects ongoing efforts to enhance transparency and integrity in scholarly publishing. While it remains a valuable tool, users should interpret it cautiously and consider additional metrics for a holistic journal evaluation248.
For more details, you can explore the Journal Citation Reports database or refer to Clarivate's official announcements8.
https://chat.deepseek.com/a/chat/s/7f887bcc-1fde-4839-b3ee-ede71c897001
转载本文请联系原作者获取授权，同时请注明本文来自许培扬科学网博客。
链接地址：https://wap.sciencenet.cn/blog-280034-1498371.html?mobile=1
收藏
